Genital Herpes Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Key Companies - Pritelivir, United Biopharma, Squarex Pharma, Novartis, EMS, Astellas Pharma Inc, GlaxoSmithKline

DelveInsight's "Genital Herpes Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Genital Herpes, historical and forecasted epidemiology as well as the Genital Herpes market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

To Know in detail about the Genital Herpes market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Genital Herpes Market Forecast
https://www.delveinsight.com/report-store/genital-herpes-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Genital Herpes Market Report:
• The Genital Herpes market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• WHO estimates that 3.7 billion persons under the age of 50, or 67% of the population, have oral or genital HSV-1 infection. Africa had the highest estimated infection prevalence (88%) and the Americas had the lowest (45%)
• More women than men are infected with HSV-2, according to the WHO. According to estimates, 178 million males and 313 million women were infected. This is due to the fact that male to female sexual transmission of HSV is more effective than female to male sexual transmission
• The introduction of new products, including those by OrganiCare's FemiClear and Perrigo's Zovirax Cream, would help the genital herpes industry develop. Both companies plan to introduce their new products in 2020.
• While Zovirax contains acyclovir and can be used to prevent subsequent genital herpes issues, Femiclear is an over-the-counter medication used to treat the symptoms of genital herpes
• Key Genital Herpes Companies: Pritelivir, United Biopharma, Squarex Pharma, Novartis, EMS, Astellas Pharma Inc, GlaxoSmithKline, Labo'Life, and others
• Key Genital Herpes Therapies: Acoricus, UB-621, SQX770, Famciclovir, Aciclovir, ASP2151, Valaciclovir, 2LHERP®, and others
• The Genital Herpes epidemiology based on gender analyzed that HSV-2 infection is more common among women than among men
• The Genital Herpes market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Genital Herpes pipeline products will significantly revolutionize the Genital Herpes market dynamics.

Genital Herpes Overview
Herpes simplex virus 1 (HSV1) and herpes simplex virus 2 (HSV2) are the two viruses that cause the sexually transmitted disease known as genital herpes (GH). It is characterised by a persistent infection and reactivation on occasion that is incurable. The mucous membranes that cover the nose, mouth, and genital openings allow viruses to enter the body. In the bodily secretions of an infected person, HSV1 and HSV2 are detected.

Get a Free sample for the Genital Herpes Market Report
https://www.delveinsight.com/sample-request/genital-herpes-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Genital Herpes Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Genital Herpes Epidemiology Segmentation:
The Genital Herpes market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Genital Herpes
• Prevalent Cases of Genital Herpes by severity
• Gender-specific Prevalence of Genital Herpes
• Diagnosed Cases of Episodic and Chronic Genital Herpes

Download the report to understand which factors are driving Genital Herpes epidemiology trends @ Genital Herpes Epidemiology Forecast
https://www.delveinsight.com/sample-request/genital-herpes-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Genital Herpes Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Genital Herpes market or expected to get launched during the study period. The analysis covers Genital Herpes market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Genital Herpes Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Genital Herpes Therapies and Key Companies
• Acoricus: Pritelivir
• UB-621: United Biopharma
• SQX770: Squarex Pharma
• Famciclovir: Novartis
• Aciclovir: EMS
• ASP2151: Astellas Pharma Inc
• Valaciclovir: GlaxoSmithKline
• 2LHERP®: Labo'Life

Discover more about therapies set to grab major Genital Herpes market share @ Genital Herpes Treatment Market
https://www.delveinsight.com/sample-request/genital-herpes-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Scope of the Genital Herpes Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Genital Herpes Companies: Pritelivir, United Biopharma, Squarex Pharma, Novartis, EMS, Astellas Pharma Inc, GlaxoSmithKline, Labo'Life, and others
• Key Genital Herpes Therapies: Acoricus, UB-621, SQX770, Famciclovir, Aciclovir, ASP2151, Valaciclovir, 2LHERP®, and others
• Genital Herpes Therapeutic Assessment: Genital Herpes current marketed and Genital Herpes emerging therapies
• Genital Herpes Market Dynamics: Genital Herpes market drivers and Genital Herpes market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Genital Herpes Unmet Needs, KOL's views, Analyst's views, Genital Herpes Market Access and Reimbursement

To know more about Genital Herpes companies working in the treatment market, visit @ Genital Herpes Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/genital-herpes-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Genital Herpes Market Report Introduction
2. Executive Summary for Genital Herpes
3. SWOT analysis of Genital Herpes
4. Genital Herpes Patient Share (%) Overview at a Glance
5. Genital Herpes Market Overview at a Glance
6. Genital Herpes Disease Background and Overview
7. Genital Herpes Epidemiology and Patient Population
8. Country-Specific Patient Population of Genital Herpes
9. Genital Herpes Current Treatment and Medical Practices
10. Genital Herpes Unmet Needs
11. Genital Herpes Emerging Therapies
12. Genital Herpes Market Outlook
13. Country-Wise Genital Herpes Market Analysis (2019-2032)
14. Genital Herpes Market Access and Reimbursement of Therapies
15. Genital Herpes Market Drivers
16. Genital Herpes Market Barriers
17. Genital Herpes Appendix
18. Genital Herpes Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:
Genital Herpes Pipeline
https://www.delveinsight.com/report-store/genital-herpes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Genital Herpes Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Genital Herpes market. A detailed picture of the Genital Herpes pipeline landscape is provided, which includes the disease overview and Genital Herpes treatment guidelines.
Genital Herpes Epidemiology
https://www.delveinsight.com/report-store/genital-herpes-epidemiology?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Genital Herpes Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Genital Herpes epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
Scedosporium Infection Market https://www.delveinsight.com/report-store/scedosporium-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Scedosporium Infection Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Scedosporium Infection, historical and forecasted epidemiology as well as the Scedosporium Infection market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Vascular Graft Devices Market https://www.delveinsight.com/report-store/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2027 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.

Vascular Stents Market https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2027 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population.

Vein Illumination Devices Market https://www.delveinsight.com/report-store/vein-illumination-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2027" report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Bladder Scanners Market https://www.delveinsight.com/report-store/bladder-scanners-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2027" report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Recent Blog's By DelveInsight:

• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistr https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr

Media Contact

Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.